Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: reporting extended results from phase III clinical trials. National Multiple Sclerosis Society Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
Goodkin
D E
DE
UCSF/MT Zion Multiple Sclerosis Center, San Francisco, CA 95115, USA.
Reingold
S
S
Sibley
W
W
Wolinsky
J
J
McFarland
H
H
Cookfair
D
D
Lublin
F
F
D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic